X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 45 filers reported holding X4 PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $85,812 | +67.2% | 61,735 | +0.9% | 0.00% | – |
| Q4 2023 | $51,315 | -23.4% | 61,198 | -0.4% | 0.00% | – |
| Q3 2023 | $66,975 | -41.7% | 61,445 | +3.7% | 0.00% | -100.0% |
| Q2 2023 | $114,966 | +41.9% | 59,261 | +532.5% | 0.00% | – |
| Q1 2021 | $81,000 | +35.0% | 9,370 | +0.3% | 0.00% | – |
| Q4 2020 | $60,000 | -7.7% | 9,346 | -2.8% | 0.00% | – |
| Q3 2020 | $65,000 | -29.3% | 9,614 | -2.2% | 0.00% | – |
| Q2 2020 | $92,000 | +1.1% | 9,832 | +7.7% | 0.00% | – |
| Q1 2020 | $91,000 | +13.8% | 9,131 | +22.9% | 0.00% | – |
| Q4 2019 | $80,000 | -15.8% | 7,431 | -0.9% | 0.00% | – |
| Q3 2019 | $95,000 | +41.8% | 7,495 | +68.8% | 0.00% | – |
| Q2 2019 | $67,000 | +570.0% | 4,439 | +705.6% | 0.00% | – |
| Q1 2019 | $10,000 | – | 551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 2,300,315 | $4,462,611 | 4.69% |
| Stonepine Capital Management, LLC | 4,605,263 | $8,934,210 | 3.22% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $30,963,541 | 3.19% |
| Tri Locum Partners LP | 4,099,943 | $7,953,889 | 2.96% |
| NEA Management Company, LLC | 14,986,793 | $29,074,378 | 2.22% |
| Lynwood Capital Management Inc. | 525,000 | $1,018,500 | 1.29% |
| Parkman Healthcare Partners LLC | 3,766,593 | $7,307,190 | 1.27% |
| Sio Capital Management, LLC | 1,749,003 | $3,393,066 | 0.86% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $649,900 | 0.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $3,828,945 | 0.36% |